JAN 27, 2017 01:49 PM PST

A.I. on Par With Doctors in Diagnosing Melanoma

WRITTEN BY: Xuan Pham

Can a smartphone be smart enough to warn users if their mole is actually deadly skin cancer? Not quite yet, but scientists from Stanford are marching in that direction. Recently, they made a huge step by developing and training an artificial intelligence (AI) software to diagnose melanoma. The AI, researchers say, has nearly the same accuracy as trained doctors.

Motivated by the desire for universal access to health care, doctors repurposed an AI software from Google that could differentiate between pictures of cats versus dogs. Using this software, the team trained the AI on database of nearly 130,000 images of skin conditions, curated to represent over 2,000 different diseases. This allowed the machine to learn the hallmarks of skin abnormalities. And instead of cats versus dogs, the machine can differentiate between benign moles and malignant melanomas.

“We realized it was feasible, not just to do something well, but as well as a human dermatologist,” said Sebastian Thrun, an adjunct professor in the Stanford Artificial Intelligence Laboratory, and the study’s senior author. “That’s when our thinking changed. That’s when we said, ‘Look, this is not just a class project for students, this is an opportunity to do something great for humanity.’”

Stanford scientists then pitted their AI against 21 trained dermatologists. They found that the AI performed as good as the human doctors. The AI achieved “performance on par with all tested experts…, demonstrating an artificial intelligence capable of classifying skin cancer with a level of competence comparable to dermatologists,” the authors wrote in their paper, published in Nature

While doctors and pathologists are still quite vital to confirming the diagnosis, the Stanford team are excited about the prospects of integrating the AI for public use. In particular, they hope to incorporate the technology into smartphones, taking full advantage of the widespread use of these mobile devices.

"The application of AI to healthcare is, we believe, an incredibly exciting area of research that can be leveraged to achieve a great deal of societal good," said Andre Esteva, the study’s lead author. "One particular route that we find exciting is the use of this algorithm on a mobile device, but to achieve this we would have to build an app and test its accuracy directly from a mobile device."

On an even grander scale, Esteva hopes medical AI may soon apply to other diseases other than melanoma. “Everyone will have a supercomputer in their pockets with a number of sensors in it, including a camera. What if we could use it to visually screen for skin cancer? Or other ailments?”

Before that happens, however, the Stanford team’s melanoma AI detector must be rigorously tested in clinics. And even then, it may be unlikely that AI will completely replace human doctors. And this may just be for the better. 

Additional sources: Stanford University,  BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 14, 2019
Cancer
OCT 14, 2019
Will Light Therapy Edge Out Opioids for Cancer Mouth Pain?
Photobiomodulation therapy, a form of low-dose light therapy, has now been found to be one of the best ways to treat the pain of oral mucositis, the mouth ...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Aspirin Usage Improves Liver Function After Embolization Treatment
Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving ...
OCT 14, 2019
Cancer
OCT 14, 2019
Antibiotic use associated with bowel cancer
From 2000–2010, global consumption of antibiotics rose by 35% up to 70 billion doses each year. Although doctors are more cautious to prescribe antib...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
How does a drug for colorectal cancer work?
Colorectal cancer is a fatal and common disease, and treatment decisions are often based on what genes have been mutated in the development of the cancer. ...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
How Liquid Biopsies Can Teach Us About Cancer Drug Resistance
Cancer patients often endure challenging treatment courses to shrink their tumors, but the tumors can make a powerful comeback....
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
A Cancer-Promoting Mutation is Found in 'Junk' DNA
A huge amount of our genome does not code for protein, but it can impact physiology in other ways....
Loading Comments...